Within the tumor compartment, we did not find significant differences in biomarkers of T-cell infiltration (CD3 or CD8), myeloid or immune checkpoint biomarker expression or biomarkers associated with cell death or PI3K/AKT signaling pathways. Here, AKT1 is linked to neoplasm.